MAHONEY DAVID L 4

4 · CORCEPT THERAPEUTICS INC · Filed May 20, 2025

Form 4

Period: 2025-05-16

Director

Transactions

Exercise/Conversion
Common Stock
2025-05-16$6.55/sh+30,000$196,500→ 30,000 total
Tax Payment
Common Stock
2025-05-16$74.21/sh−2,648$196,508→ 27,352 total
Exercise/Conversion
Stock option (right to buy)
2025-05-16−30,000→ 0 total
Exercise: $6.55Exp: 2025-06-18→ Common Stock (30,000 underlying)
Sale
Common Stock
2025-05-16$74.17/sh−23,829$1,767,452→ 3,523 total
Sale
Common Stock
2025-05-16$74.65/sh−3,523$263,001→ 0 total

Holdings

Footnotes (4)

[F1]These shares were withheld so the Reporting Person could satisfy the exercise price liability arising from a net (cashless) exercise of stock options that occurred on May 16, 2025. The options subject to the net exercise were to expire on June 18, 2025.
[F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.54 to $74.525 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
[F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $74.54 to $74.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
[F4]Fully exercisable.

Documents

1 file